There was no significant difference in serum TGF- β 1 and MMP-9 levels among subjects with different age, tumor size and menopausal status, indicating that the levels of TGF- β 1 and MMP-9 were related to clinical stage, histological grade, lymph node metastasis and molecular classification of BC. This evidence concerns the gene MMP9 and neoplasm.